Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.
(Studio: Peter Jennings) Report introduced. [Health and Human Services Secretary Tommy THOMPSON - announces a medical breakthrough.]
(Washington: Jackie Judd) Government approval of the new cancer drug Gleevec for treating chronic myeloid leukemia featured. [THOMPSON - says the drug appears to change the odds for patients.] [Leukemia PATIENT, National Cancer Institute Richard KLAUSNER - comment on the drug.] [Oregon Health Sciences University Dr. Brian DRUKER - cites the lack of insurance coverage for the drug.]
(Studio: Peter Jennings) The fact that patients over 65 will not have access to Gleevec because Medicare does not pay for prescription drugs noted. [KLAUSNER - says Medicare rules will have to be evaluated.]
(Studio: Peter Jennings, Boston: Tim Johnson) The significance of this cancer drug in that it targets cancer cells alone and the issue of pressure on insurance and Medicare to pay for it discussed.
- Johnson, Tim;
- Jennings, Peter;
- Judd, Jackie
Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.
Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:
- You may request a loan of this video by registering on our website and placing an order.
- You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
- If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.
If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.